The Big Pharmaceutical companies have had a slow going year. Many of them are trading right where they started in 2010 or even lower. Although there have been winners such as Genzyme (GENZ), who received a bid from Sanofi-Aventis (SNY) and now trades near $70 after starting the year under $50, most of... Read more
Posts Tagged ‘Value Stocks’
